Nvelop Therapeutics
Signal active
Organization
Contact Information
Overview
Nvelop Therapeutics is a biotechnology company that provides gene editing technology services for unmet major disease needs.
About
Industries
Biotechnology, Medical, Genetics
Founded
2022
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Nvelop Therapeutics headquartered in United States, North America, operates in the Biotechnology, Medical, Genetics sector. The company focuses on Biotechnology and has secured $1.2B in funding across 12 round(s). With a team of 11-50 employees, Nvelop Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Nvelop Therapeutics, raised $100.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
4
Lead Investors
0
Total Funding Amount
$100.0M
Details
1
Nvelop Therapeutics has raised a total of $100.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Seed | 100.0M |
Investors
Nvelop Therapeutics is funded by 6 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Nvelop Therapeutics | - | FUNDING ROUND - Nvelop Therapeutics | 100.0M |
| Atlas Venture | - | FUNDING ROUND - Atlas Venture | 100.0M |
| Nvelop Therapeutics | - | FUNDING ROUND - Nvelop Therapeutics | 100.0M |
| Newpath Management | - | FUNDING ROUND - Newpath Management | 100.0M |
Recent Activity
There is no recent news or activity for this profile.